STOCKHOLDERS' EQUITY AND DILUTIVE EQUITY INSTRUMENTS

9 Months Ended

Sep. 30, 2019

STOCKHOLDERS' EQUITY AND DILUTIVE EQUITY INSTRUMENTS

(5)	STOCKHOLDERS' EQUITY AND DILUTIVE EQUITY INSTRUMENTS

Accumulated Other Comprehensive Income (Loss)

The following table summarizes the reclassifications from accumulated other comprehensive income (loss) to the condensed consolidated statement of operations for the three and nine months ended September 30, 2019 and 2018:

	Three Months Ended					Nine Months Ended					Affected line item in the condensed
(In thousands)	September 30, 2019		September 30, 2018			September 30, 2019		September 30, 2018			consolidated statements of operations
Balance at beginning of period	$	2,194		(403	)		2,194		(147	)
Losses recognized in OCI									(660	)
Realized gains on available for sale securities		—		—			—		404		Interest income and other, net
Net period OCI		—		—			—		(256	)
Tax effect		—		—			—		—
Total gains for the period, net of tax		—		0			—		(256	)
Balance at end of period	$	2,194		(403	)		2,194		(403	)

Dilutive Equity Instruments

We had 3,397,110 and 5,143,206 incremental "in-the-money" warrants and restricted stock awards and units at September 30, 2019 and 2018, respectively.

Common shares and creditor warrants and the sum of common shares and creditor warrants outstanding at September 30, 2019 and 2018 were as follows:

Total shares outstanding including warrants	September 30, 2019		September 30, 2018
Common shares outstanding		39,110,938		26,815,991
New Creditor Warrants (strike price $0.001 per common share)		1,329,884		3,512,416
GulfMark Creditor Warrants (strike price $0.01 per common share)		1,300,359		—
Total		41,741,181		30,328,407

We also had 5,923,399 and 5,062,089 “out-of-the-money” warrants outstanding at September 30, 2019 and 2018, respectively. Included in these “out-of-the-money” warrants are Series A Warrants, Series B Warrants and GLF Equity Warrants which have exercise prices of $57.06, $62.28 and $100, respectively.